Recent Advances in Managementof Prostate Cancer
Journal Title: Journal of Oncobiomarkers - Year 2017, Vol 3, Issue 1
Abstract
Prostate cancer is the second most common cancer in males worldwide and the incidence is increasing due to ageing population, screening facilities and rising awareness. This is a disease of the elderly and is biologically less aggressive as compared to some other malignancies. Most of the patients present with organ-confined disease, thus the age adjusted death rates are declining due to early detection and timely intervention. The various treatment options include external radiotherapy, brachytherapy or radical prostatectomy for low-risk early stage disease; hormonal therapy and external radiotherapy for advanced high-risk cases; and hormonal therapy, palliative radiotherapy with or without chemotherapy for metastatic disease. The main aim of this article is to sensitize the readers with the recent advances in management of cancer prostate.
Authors and Affiliations
Virender Suhag
Keywords
Related Articles
- EP ID EP245949
- DOI 10.13188/2325-2340.1000011
- Views 93
- Downloads 0
Chemokine Receptors as Biomarkers in Head and Neck Squamous Cell Carcinoma
Head and neck squamous cell carcinoma (HNSCC) is reported to be the 6th most common solid tumor diagnosed in the world [1]. Around 95% head and neck cancers are squamous cell carcinomas originating in the upper aerod...
Proteasome Subunit LMP2/β1i as a Biomarker for Human Uterine Mesenchymal Tumors
The proteasomal degradation pathway is essential for many cellular processes, including the cell cycle, regulation of gene expression, and responses to oxidative stress. The proteasome most exclusively used in mammals is...
11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal Tumorigenesis
Colorectal cancer (CRC) is a leading cause of cancer death, yet primary prevention remains the best approach to reducing overall morbidity and mortality. There is a clear molecular link between cyclooxygenase-2 (COX-2)-d...
Low Cell Density Induced Epithelial-Mesenchymal Transition in MCF10A Cell is Regulated by Proteasome Activity
Epithelial-mesenchymal transition (EMT) is a key process in tumor progression and metastasis. Previous studies have shown that MCF10A human mammary epithelial cells undergo EMT when cultured at low cell density, but...
IRF4 as an Oncogenic Biomarker for Hematological Malignancies
The lymphocyte-specific transcription factor Interferon (IFN) Regulatory Factor 4 (IRF4) is crucial for lymphocyte development. Importantly, IRF4 has potent oncogenic and transforming properties, and its intimate interac...